ω-3 and ω-6 polyunsaturated fatty acids enhance arsenic trioxide efficacy in arsenic trioxide-resistant leukemic and solid tumor cells

Oncology Research

Volumn 18, Issue 2-3, 2009, Pages 83-94

  Wirtitsch, Melanie ^a   Roth, Erich ^a   Bachleitner Hofmann, Thomas ^a   Wessner, Barbara ^a   Sturlan, Sanda ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Apoptosis; Arsenic trioxide; Lipid peroxidation; Polyunsaturated fatty acids; Tumor cells

Indexed keywords

ALPHA TOCOPHEROL; ARACHIDONIC ACID; ARSENIC TRIOXIDE; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; LIPOCORTIN 5; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PROPIDIUM IODIDE; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; ANTINEOPLASTIC AGENT; ORGANOARSENIC DERIVATIVE; OXIDE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CELL VIABILITY; CHEMOSENSITIVITY; COLORIMETRY; CONTROLLED STUDY; DNA DETERMINATION; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL; LIPID PEROXIDATION; MONOTHERAPY; PRIORITY JOURNAL; SKIN FIBROBLAST; SOLID TUMOR; STAINING; DRUG EFFECT; DRUG RESISTANCE; LEUKEMIA; METABOLISM; NEOPLASM; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ARACHIDONIC ACID; ARSENICALS; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; HUMANS; LEUKEMIA; LIPID PEROXIDATION; NEOPLASMS; OXIDES; VITAMIN E;

EID: 75649121115     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504009789954654     Document Type: Article

References (40)

1. Germain, E.; Chajes, V.; Cognault, S.; Lhuillery, C.; Bougnoux, P. Enhancement of doxorubicin cytotoxicity by polyunsaturated fatty acids in the human breast tumor cell line MDA-MB-231: relationship to lipid peroxidation. Int. J. Cancer 75(4):578-583; 1998.
2. Maziere, C.; Conte, M. A.; Degonville, J.; Ali, D.; Maziere, J. C. Cellular enrichment with polyunsaturated fatty acids induces an oxidative stress and activates the transcription factors AP1 and NFkappaB. Biochem. Biophys. Res. Commun. 265(1):116-122; 1999.
3. Menendez, J. A.; del Mar Barbacid, M.; Montero, S.; Sevilla, E.; Escrich, E.; Solanas, M.; Cortes-Funes, H.; Colomer, R. Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells. Eur. J. Cancer 37(3):402-413; 2001.
4. Germain, E.; Lavandier, F.; Chajes, V.; Schubnel, V.; Bonnet, P.; Lhuillery, C.; Bougnoux, P. Dietary n-3 polyunsaturated fatty acids and oxidants increase rat mammary tumor sensitivity to epirubicin without change in cardiac toxicity. Lipids 34:S203; 1999. (Pubitemid 29323194)
5. Hardman, W. E.; Avula, C. P.; Fernandes, G.; Cameron, I. L. Three percent dietary fish oil concentrate increased efficacy of doxorubicin against MDA-MB 231 breast cancer xenografts. Clin. Cancer Res. 7(7):204-249; 2001.
6. Shao, Y.; Pardini, L.; Pardini, R. S. Dietary menhaden oil enhances mitomycin C antitumor activity toward human mammary carcinoma MX-1. Lipids 30(11):1035-1045; 1995.
7. Shao, Y.; Pardini, L.; Pardini, R. S. Intervention of transplantable human mammary carcinoma MX-1 chemotherapy with dietary menhaden oil in athymic mice: increased therapeutic effects and decreased toxicity of cyclophosphamide. Nutr. Cancer 28(1):63-73; 1997.
8. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 89(9):3354-3360; 1997.
9. Soignet, S. L.; Maslak, P.; Wang, Z. G.; Jhanwar, S.; Calleja, E.; Dardashti, L. J.; Corso, D.; DeBlasio, A.; Gabrilove, J.; Scheinberg, D. A.; Pandolfi, P. P.; Warrell, R. P. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N. Engl. J. Med. 339(19):1341-1348; 1998.
10. Tallman, M. S. Therapy of acute promyelocytic leukemia: all-trans retinoic acid and beyond. Leukemia 12(Suppl. 1): S37-40; 1998.
11. Soignet, S. L. Clinical experience of arsenic trioxide in relapsed acute promyelocytic leukemia. Oncologist 6(Suppl. 2):11-16; 2001.
12. Huang, X. J.; Wiernik, P. H.; Klein, R. S.; Gallagher, R. E. Arsenic trioxide induces apoptosis of myeloid leukemia cells by activation of caspases. Med. Oncol. 16(1): 58-64; 1999.
13. Zhu, X. H.; Shen, Y. L.; Jing, Y. K.; Cai, X.; Jia, P. M.; Huang, Y.; Tang, W.; Shi, G. Y.; Sun, Y. P.; Dai, J.; Wang, Z. Y.; Chen, S. J.; Waxman, S.; Chen, Z.; Chen, G. Q. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. J. Natl. Cancer Inst. 91(9): 772-778; 1999.
14. Uslu, R.; Sanli, U. A.; Sezgin, C.; Karabulut, B.; Terzioglu, E.; Omay, S. B.; Goker, E. Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines. Clin. Cancer Res. 6(12):4957-4964; 2000.
15. Ling, Y. H.; Jiang, J. D.; Holland, J. F.; Perez-Soler, R. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines. Mol. Pharmacol. 62(3):529-538; 2002.
16. Sturlan, S.; Baumgartner, M.; Roth, E.; Bachleitner-Hofmann, T. Docosahexaenoic acid enhances arsenic trioxide-mediated apoptosis in arsenic trioxide-resistant HL-60 cells. Blood 101(12):4990-4997; 2003.
17. Baumgartner, M.; Sturlan, S.; Roth, E.; Wessner, B.; Bachleitner-Hofmann, T. Enhancement of arsenic trioxide-mediated apoptosis using docosahexaenoic acid in arsenic trioxide-resistant solid tumor cells. Int. J. Cancer 112(4):707-712; 2004.
18. Soignet, S. L.; Tong, W. P.; Hirschfeld, S.; Warrell, R. P. J. Clinical study of an organic arsenical, melarsoprol, in patients with advanced leukemia. Cancer Chemother. Pharmacol. 44(5):417-421; 1999.
19. Akao, Y.; Nakagawa, Y.; Akiyama, K. Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro. FEBS Lett. 455(1-2):59-62; 1999.
20. Seol, J. G.; Park, W. H.; Kim, E. S.; Jung, C. W.; Hyun, J. M.; Kim, B. K.; Lee, Y. Y. Effect of arsenic trioxide on cell cycle arrest in head and neck cancer cell line PCI-1. Biochem. Biophys. Res. Commun. 265(2):400-404; 1999.
21. Yang, C. H.; Kuo, M. L.; Chen, J. C.; Chen, Y. C. Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells. Br. J. Cancer 81(5):796-799; 1999.
22. Maeda, H.; Hori, S.; Nishitoh, H.; Ichijo, H.; Ogawa, O.; Kakehi, Y.; Kakizuka, A. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer. Cancer Res. 61(14):5432-5440; 2001.
23. 3-induced c-Src/EGFR/ERK signaling is via Sp1 binding sites to stimulate p21WAF1/ CIP1 expression in human epidermoid carcinoma A431 cells. Cell Signal. 18(2):244-255; 2006.
24. Xiao, Y. F.; Liu, S. X.; Wu, D. D.; Chen, X.; Ren, L. F. Inhibitory effect of arsenic trioxide on angiogenesis and expression of vascular endothelial growth factor in gastric cancer. World J. Gastroenterol. 12(36):5780-5786; 2006.
25. Jing, Y.; Dai, J.; Chalmers-Redman, R. M.; Tatton, W. G.; Waxman, S. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood 94(6):2102-2111; 1999.
26. Hyun Park, W.; Hee Cho, Y.; Won Jung, C.; Oh Park, J.; Kim, K.; Hyuck Im, Y.; Lee, M. H.; Ki Kang, W.; Park, K. Arsenic trioxide inhibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis. Biochem. Biophys. Res. Commun. 300(1):230-235; 2003.
27. 3)-induced apoptosis in human glioblastoma cells. Cancer Sci. 96(11): 825-833; 2005.
28. Bachleitner-Hofmann, T.; Gisslinger, B.; Grumbeck, E.; Gisslinger, H. Arsenic trioxide and ascorbic acid: Synergy with potential implications for the treatment of acute myeloid leukaemia? Br. J. Haematol. 112(3):783-786; 2001.
29. Wang, Z. G.; Rivi, R.; Delva, L.; Konig, A.; Scheinberg, D. A.; Gambacorti-Passerini, C.; Gabrilove, J. L.; Warrell, Jr., R. P.; Pandolfi, P. P. Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent manner. Blood 92(5):1497-1504; 1998.
30. Miller, W. H. J.; Schipper, H. M.; Lee, J. S.; Singer, J.; Waxman, S. Mechanisms of action of arsenic trioxide. Cancer Res. 62(14):3893-3903; 2002.
31. Dai, J.; Weinberg, R. S.; Waxman, S.; Jing, Y. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 93:268-277; 1999.
32. Vibet, S.; Goupille, C.; Bougnoux, P.; Steghens, J. P.; Goré, J.; Mahéo, K. Sensitization by docosahexaenoic acid (DHA) of breast cancer cells to anthracyclines through loss of glutathione peroxidase (GPx1) response. Free Rad. Biol. Med. 44(7):1483-1491; 2008.
33. Kinsella, J. E.; Black, J. M. Effects of polyunsaturated fatty acids on the efficacy of antineoplastic agents towards L5178Y lymphoma cells. Biochem. Pharmacol. 45:1881-1887; 1993.
34. Liu, Q. Y.; Tan, B. K. Effects of cis-unsaturated fatty acids on doxorubicin sensitivity in P-388/DOX-resitant and P388 parental cell lines. Life Sci. 67:1207-1218; 2000.
35. Pompeia, C.; Freitas, J. J. S.; Kim, J. S.; Zyngier, S. B.; Curi, R. Arachidonic acid cytotoxicity in leukocytes: Implications of oxidative stress and eicosanoid synthesis. Biol. Cell 94(4-5):251-265; 2002.
36. Surette, M. E.; Fonteh, A. N.; Bernatchez, C.; Chilton, F. H. Perturbations in the control of cellular arachidonic acid levels block cell growth and induce apoptosis in HL-60 cells. Carcinogenesis 20(5):757-763; 1999.
37. Tang, D. G.; La, E.; Kern, J.; Kehrer, J. P. Fatty acid oxidation and signaling in apoptosis. Biol. Chem. 383(3-4): 425-442; 2002.
38. Das, U. N.; Begin, M. E.; Ells, G.; Huang, Y. S.; Horrobin, D. F. Polyunsaturated fatty acids augment free radical generation in tumor cells in vitro. Biochem. Biophys. Res. Commun. 145(1):15-24; 1987.
39. Finstad, H. S.; Myhrstad, M. C.; Heimli, H.; Lomo, J.; Blomhoff, H. K.; Kolset, S. O.; Drevon, C. A. Multiplication and death-type of leukemia cell lines exposed to very long-chain polyunsaturated fatty acids. Leukemia 12(6): 921-929; 1998.
40. Higuchi, Y.; Yoshimoto, T. Arachidonic acid converts the glutathione depletion-induced apoptosis to necrosis by promoting lipid peroxidation and reducing caspase-3 activity in rat glioma cells. Arch. Biochem. Biophys. 400(1): 133-140; 2002.